Novartis hit with another serious drug marketing breach, this time for multiple sclerosis...

[cafead]

via The U.K. drug marketing body, the Prescription Medicines Code of Practice Authority (PMCPA), is once again taking action against Novartis' U.K. business, which has become a repeat offender in terms of "bringing discredit upon, and reducing confidence in, the pharmaceutical industry."

article source